Tag: drug companies
Pervasive Industry Influence in Healthcare Sector Harms Patients
Experts across the globe point to the harms of drug companies’ influence on research, practice, and education in healthcare noting that it compromises patient care.
Big Pharma Might Be Intentionally Confusing You
From Benzinga: The FDA has suggested that drug commercials may intentionally list potential side effects in such a rapid-fire, overwhelming way that the warning messages...
Ohio Attorney General Sues Prescription Opioid Manufacturers
Ohio Attorney General Mike DeWine has filed a lawsuit against five leading prescription opioid manufacturers and their related companies in Ross County Court of Common...
“Selling Side Effects: Big Pharma’s Marketing Machine?”
Drug Watch releases an in-depth investigation into the marketing practices of pharmaceutical companies in the United States. “Companies spend billions advertising to doctors to...
“What Drug Ads Don’t Say”
For the New York Times, Cornell psychiatrist Richard Friedman proposes new regulations to make direct-to-consumer drug ads reveal the relative price and effectiveness information that...
“Why You Should Stop Taking Your Antidepressants”
The New York Post reprints an excerpt on antidepressants from the latest book by MIA contributor, Kelly Brogan, MD, “A Mind of Your Own:...
“As Opioid Deaths Reach Record High, Drug Industry Resists Efforts to...
“In 2014, the number of people who died from drug overdoses in the United States reached 47,055 — an all-time high, according to a disturbing report published Friday by the Centers for Disease Control and Prevention (CDC),” but “the effort to get physicians to curb their prescribing of these drugs may be faltering amid stiff resistance from drugmakers, industry-funded groups and, now, even other public health officials.”
Book Review: “Overmedicated and Undertreated”
A former pharma executive has broken ranks with the industry in a new book by reporting how multiple psychiatrists, schools, and his desperate hopes pressed him to allow higher and higher doses of antipsychotic medications. The result: his 15-year-old son's death from Seroquel.
“Would Washington’s FDA Fix Cure the Patients or the Drug Industry?”
Legislation is being advanced that would speed up the FDA’s approval process for new drugs and medical devices, according to a report by the Pacific Standard. Pharmaceutical and medical device companies have been lobbying heavily to reduce regulations and are winning over bipartisan support by attaching these measures to increased mental health funding.
